Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-3.53%)
Close on Nov 12, 2026Market cap $5.67MP/E –Yield –
Tempest Therapeutics cash
Cash and short-term investments held at the end of each period.
Tempest Therapeutics's cash was $779.00K at Jun 30, 2026. For fiscal 2025 it was $7.71M, down 74.9% from the year before. Over ten years it grew -24.4% a year on average. The highest annual figure on record is $126.70M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.71M | -74.9% |
| FY2024 | Dec 31, 2024 | $30.71M | -22.6% |
| FY2023 | Dec 31, 2023 | $39.67M | +25.6% |
| FY2022 | Dec 31, 2022 | $31.60M | -39.0% |
| FY2021 | Dec 31, 2021 | $51.83M | +33.9% |
| FY2020 | Dec 31, 2020 | $38.70M | -39.1% |
| FY2019 | Dec 31, 2019 | $63.50M | -18.3% |
| FY2018 | Dec 31, 2018 | $77.70M | +15.6% |
| FY2017 | Dec 31, 2017 | $67.20M | -41.3% |
| FY2016 | Dec 31, 2016 | $114.40M | -9.7% |
| FY2015 | Dec 31, 2015 | $126.70M | +110.5% |
| FY2014 | Dec 31, 2014 | $60.20M | +35.6% |
| FY2013 | Dec 31, 2013 | $44.40M | +41.4% |
| FY2012 | Dec 31, 2012 | $31.39M | +591.3% |
| FY2011 | Dec 31, 2011 | $4.54M | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $779.00K | -94.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.81M | -91.8% |
| Q4 FY2025 | Dec 31, 2025 | $7.71M | -74.9% |
| Q3 FY2025 | Sep 30, 2025 | $7.51M | -67.2% |
| Q2 FY2025 | Jun 30, 2025 | $14.72M | -53.4% |
| Q1 FY2025 | Mar 31, 2025 | $21.95M | -33.0% |
| Q4 FY2024 | Dec 31, 2024 | $30.71M | -22.6% |
| Q3 FY2024 | Sep 30, 2024 | $22.91M | +99.1% |
| Q2 FY2024 | Jun 30, 2024 | $31.57M | +75.6% |
| Q1 FY2024 | Mar 31, 2024 | $32.77M | +40.7% |
| Q4 FY2023 | Dec 31, 2023 | $39.67M | +25.6% |
| Q3 FY2023 | Sep 30, 2023 | $11.51M | -73.3% |
| Q2 FY2023 | Jun 30, 2023 | $17.97M | -65.4% |
| Q1 FY2023 | Mar 31, 2023 | $23.29M | -49.5% |
| Q4 FY2022 | Dec 31, 2022 | $31.60M | -39.0% |
| Q3 FY2022 | Sep 30, 2022 | $43.16M | -27.8% |
| Q2 FY2022 | Jun 30, 2022 | $51.99M | -24.1% |
| Q1 FY2022 | Mar 31, 2022 | $46.12M | +68.9% |
| Q4 FY2021 | Dec 31, 2021 | $51.83M | +33.9% |
| Q3 FY2021 | Sep 30, 2021 | $59.76M | +36.4% |
| Q2 FY2021 | Jun 30, 2021 | $68.46M | +34.2% |
| Q1 FY2021 | Mar 31, 2021 | $27.30M | -53.7% |
| Q4 FY2020 | Dec 31, 2020 | $38.70M | -39.1% |
| Q3 FY2020 | Sep 30, 2020 | $43.80M | -9.3% |
| Q2 FY2020 | Jun 30, 2020 | $51.00M | -9.9% |
| Q1 FY2020 | Mar 31, 2020 | $58.90M | -12.1% |
| Q4 FY2019 | Dec 31, 2019 | $63.50M | -18.3% |
| Q3 FY2019 | Sep 30, 2019 | $48.30M | +4.1% |
| Q2 FY2019 | Jun 30, 2019 | $56.60M | +5.6% |
| Q1 FY2019 | Mar 31, 2019 | $67.00M | +14.9% |
| Q4 FY2018 | Dec 31, 2018 | $77.70M | +15.6% |
| Q3 FY2018 | Sep 30, 2018 | $46.40M | -38.7% |
| Q2 FY2018 | Jun 30, 2018 | $53.60M | -38.1% |
| Q1 FY2018 | Mar 31, 2018 | $58.30M | -41.2% |
| Q4 FY2017 | Dec 31, 2017 | $67.20M | -41.3% |
| Q3 FY2017 | Sep 30, 2017 | $75.70M | -42.2% |
| Q2 FY2017 | Jun 30, 2017 | $86.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $99.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $114.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $131.00M | – |
See a number that looks wrong?